While advances in both the treatment of cancer and the management of its complications have led to significant improvement in patient survival, infections remain a significant cause of morbidity and mortality in patients with neoplastic disease. In this patient population, infection risk results from a complex interplay between the host’s underlying immunodeficiencies, local tumor effects, and treatment-induced immunosuppression. New chemotherapeutic approaches and antimicrobial prophylaxis and treatment practices continue to shape the spectrum of infections in these patients. Clinicians who treat infections in cancer patients are continually challenged by the emergence of new pathogens and by the increasing antimicrobial resistance of established ones.
DETTAGLI PRODOTTO torna su
Titolo: Infectious Complications in Cancer Patients
Autori: Stosor - Zembower
Editore: Springer Verlag
Collana: Cancer Treatment and Research - Vol 161
Finitura: Copertina rigida